MARATTO

article · Ain Shams Dental Journal

Electrospun Poly-Lactic Acid Nanofibers for Dual Drug Delivery in Regenerative endodontics: Ciprofloxacin and Metronidazole Loading and Characterization

Abstract

Aim: This study presents the synthesis, material characterization, and evaluation of the antimicrobial activity of antibiotic-loaded scaffolds. Materials and methods: Metronidazole (MID) or Ciprofloxacin (CIP) was incorporated into a polylactic acid (PLA) polymer solution at a concentration of 25 wt.% and then processed into Fibers. Neat PLA nanofibers were used as controls. Characterization techniques, including scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), degradation tests, and drug release assessments, were employed. The antimicrobial properties were tested against Porphyromonasgingivalis (Pg) and Enterococcus faecalis (Ef). Results: SEM imaging showed Fibers with submicron diameters, and FTIR confirmed the successful incorporation of the antibiotics. Data analysis demonstrated a gradual and sustained release of the drugs from the scaffolds over 48 hours. Antimicrobial activity was confirmed via agar diffusion assays, showing efficacy against the tested bacteria. Conclusion: Antibiotic-loaded electrospun PLA scaffolds could serve as biologically safe antimicrobial drug delivery systems for use in regenerative endodontics.

Research topics

  • Endodontics and Root Canal Treatments
  • Electrospun Nanofibers in Biomedical Applications
  • Bone Tissue Engineering Materials

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/asdj.2025.342662.1709

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.